Pertuza 420 mg Injection 14 ml

Pertuza 420 mg Injection 14 ml is used in the treatment of Breast Cancer. The detailed uses of Pertuza 420 mg Injection 14 ml are as follows:

• Metastatic HER2-Positive Breast Cancer: Pertuza 420 mg Injection 14 ml is used in combination with trastuzumab and docetaxel as a first-line treatment for patients who haven’t received prior anti-HER2 therapy for metastatic disease.
• Neoadjuvant Therapy: Pertuza 420 mg Injection 14 ml is given before surgery to shrink tumors in locally advanced or early-stage HER2-positive breast cancer.
• Adjuvant Therapy: Pertuza 420 mg Injection 14 ml is used after surgery in patients with early-stage HER2-positive breast cancer who are at high risk of recurrence.

Pertuza 420 mg Injection 14 ml contains Pertuzumab, which belongs to the class of monoclonal antibodies. It works by inhibiting the excess production of a human epidermal growth factor receptor 2 (HER2) protein in the mammalian cells. This causes inhibition of the cancer cell growth and, finally, initiation of apoptosis. Pertuza 420 mg Injection 14 ml is used in combination with trastuzumab and docetaxel for the treatment of breast cancer.

• Follow your doctor’s instructions on the dosage and timing of this medication.
• Pertuza 420 mg Injection 14 ml will be administered by a nurse or doctor.
• Do not self-administer.

• Meditation and yoga have been proven very effective in helping cancer patients maintain a healthy attitude and body.
• Eat more lean meats, healthy fats, fruits, vegetables, and whole-grain foods to give you more energy. 
• Stay hydrated by drinking plenty of water, as dehydration is often seen in cancers.
• Taking a stroll in the garden or spending 30 minutes of your time doing some light physical activity can be very useful. However, do not over-exert yourself if you feel too tired. 
• Avoid smoking and alcohol consumption.

Pertuza 420 mg Injection 14 ml should be avoided if you are allergic to it or any other components of this medicine. Pertuza 420 mg Injection 14 ml may cause left ventricular dysfunction, anaphylaxis, or hypersensitivity reactions during the treatment. Hence, careful observation should be performed for any reactions in the patient. If any changes or hypersensitivity reactions occur, treatment should be discontinued. Inform your doctor if you have any cardiovascular conditions or liver/kidney disease, as it can cause adverse effects. Pertuza 420 mg Injection 14 ml is known to cause embryo-fetal toxicity. Hence, if you are pregnant or breastfeeding, inform your doctor beforehand. The use of Pertuza 420 mg Injection 14 ml along with the doxorubicin-containing regimen is not established. Hence, if you are on such treatment, inform your doctor before starting the treatment. Pertuza 420 mg Injection 14 ml is not recommended for use in children as the safety and efficacy are not established.